Prices delayed by at least 15 minutes | Print
Vaneck Ucits Etfs PLC VANECK GENOMICS & HEALTHCARE UCITS ETF
Open
£20.245
Previous close
£20.3625
Trade high
£20.245
Income frequency
-
Year low
£14.3813
Year high
£22.37
Replication method
Physical Full
Volume
276
Type
ETF
UCITS
Yes
Dividend yield
–
Ongoing charge
0.35
ISIN
IE000B9PQW54
Share price
Asset allocation
Top 10 holdings
| Holdings 13/11/2026 | % of assets |
|---|---|
| Moderna Inc | 11.13 |
| Regeneron Pharmaceuticals Inc | 9.14 |
| Vertex Pharmaceuticals Inc | 7.99 |
| Veeva Systems Inc Class A | 7.26 |
| Natera Inc | 5.60 |
| DexCom Inc | 5.28 |
| Illumina Inc | 4.88 |
| Guardant Health Inc | 4.05 |
| BioNTech SE ADR | 3.39 |
| Alnylam Pharmaceuticals Inc | 2.78 |
Investment objective
The Fund’s investment objective is to replicate the price and the performance, before fees and expenses, of an index that provides exposure to the performance of a representative portfolio of companies involved in the genomic healthcare and electronic healthcare industries.
This product is based overseas and is not subject to UK sustainable investment labelling and disclosure requirements. Learn more about SDR.